Found 4 matching trials
Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
PHASE1This is an extension study to investigate long term safety and efficacy of ...
Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
PHASE1The purpose of this study is to investigate tolerability when SyB C-1101 is...
Study of SyB C-1101 in Patients With Myelodysplastic Syndrome
PHASE1To assess tolerability of SyB C-1101 when administered orally BID for 21 da...
Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome
PHASE1This is a Phase 1 clinical trial to evaluate the tolerability of a combinat...